Merck and Co., Inc. - Specimen Stock Certificate
Inv# SE1041
Specimen Stock
Specimen Stock printed by American Bank Note Company. Merck & Co., Inc. is a prominent American multinational pharmaceutical corporation, with its headquarters located in Kenilworth, New Jersey. The company derives its name from the Merck family, who founded the Merck Group in Germany in 1668. Operating under the name Merck Sharp & Dohme (MSD) in regions outside the United States and Canada, Merck & Co. was established as an American subsidiary in 1891. The organization is engaged in the development and production of pharmaceuticals, vaccines, biologic therapies, and products for animal health. In 2020, it reported several blockbuster drugs, including those for cancer immunotherapy, diabetes management, and vaccines for HPV and chickenpox, each contributing significantly to its revenue.
In the 2021 rankings, the company was positioned 69th on the Fortune 500 list and 92nd on the Forbes Global 2000 list, both based on revenues from 2020. The company is involved in the creation of medicines, vaccines, biologic therapies, and animal health products. In 2020, it achieved notable success with six blockbuster products, each generating over $1 billion in revenue. Keytruda (pembrolizumab), a humanized antibody for cancer immunotherapy, led with $14.3 billion in revenue; Januvia (sitagliptin), an anti-diabetic drug for type 2 diabetes, followed with $5.3 billion; Gardasil, an HPV vaccine, generated $3.9 billion; Varivax, a vaccine for chickenpox, brought in $1.9 billion; Bridion (Sugammadex), a neuromuscular-blocking agent, earned $1.2 billion; and Pneumovax 23, a pneumococcal polysaccharide vaccine, contributed $1.1 billion. Additionally, other significant products include Isentress (raltegravir), an antiretroviral for HIV/AIDS with $857 million in revenue; Simponi (golimumab), an immunosuppressive monoclonal antibody with $838 million; RotaTeq, a rotavirus vaccine generating $797 million; and Lynparza (olaparib), a treatment for BRCA-mutated advanced ovarian cancer, which produced $725 million in revenue for the company.
Stock and Bond Specimens are made and usually retained by a printer as a record of the contract with a client, generally with manuscript contract notes such as the quantity printed. Specimens are sometimes produced for use by the printing company's sales team as examples of the firm’s products. These are usually marked "Specimen" and have no serial numbers.
Ebay ID: labarre_galleries